Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 11, 2020

SELL
$15.6 - $54.87 $1.09 Million - $3.84 Million
-70,000 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$15.0 - $16.6 $1.05 Million - $1.16 Million
70,000 New
70,000 $1.12 Million

Others Institutions Holding IMRA

About IMARA Inc.


  • Ticker IMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,287,300
  • Market Cap $552M
  • Description
  • IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...
More about IMRA
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.